Physician profile
David Gavin
NPI 1871541680
$5,101.52
in general payments reported to CMS, 2019-2025
6 companies · $4,112 in 2025
The $4,112 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.22 · 2023: $904 · 2025: $4,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $3,900 · Travel and Lodging: $700 · Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $3,900.00 |
| Travel and Lodging | $700.15 |
| Food and Beverage | $416.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $4,789.32 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $122.80 | 2025 | Nuzyra |
| Djo, LLC | $89.10 | 2025 | Cmf |
| Horizon Therapeutics Plc | $53.43 | 2019 | |
| Cardiovascular Systems INC. | $31.79 | 2019 | |
| Organogenesis INC. | $15.08 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gavin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.